| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.05 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.05 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.33 | 0.05 |